138 related articles for article (PubMed ID: 8077254)
1. In vivo versus in vitro degradation of controlled release polymers for intracranial surgical therapy.
Wu MP; Tamada JA; Brem H; Langer R
J Biomed Mater Res; 1994 Mar; 28(3):387-95. PubMed ID: 8077254
[TBL] [Abstract][Full Text] [Related]
2. Optimizing interstitial delivery of BCNU from controlled release polymers for the treatment of brain tumors.
Sipos EP; Tyler B; Piantadosi S; Burger PC; Brem H
Cancer Chemother Pharmacol; 1997; 39(5):383-9. PubMed ID: 9054951
[TBL] [Abstract][Full Text] [Related]
3. Implantable polymers for tirapazamine treatments of experimental intracranial malignant glioma.
Yuan X; Tabassi K; Williams JA
Radiat Oncol Investig; 1999; 7(4):218-30. PubMed ID: 10492162
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of in vitro and in vivo antitumor activity of BCNU-loaded PLGA wafer against 9L gliosarcoma.
Lee JS; An TK; Chae GS; Jeong JK; Cho SH; Lee HB; Khang G
Eur J Pharm Biopharm; 2005 Jan; 59(1):169-75. PubMed ID: 15567315
[TBL] [Abstract][Full Text] [Related]
5. Local delivery of minocycline and systemic BCNU have synergistic activity in the treatment of intracranial glioma.
Frazier JL; Wang PP; Case D; Tyler BM; Pradilla G; Weingart JD; Brem H
J Neurooncol; 2003 Sep; 64(3):203-9. PubMed ID: 14558595
[TBL] [Abstract][Full Text] [Related]
6. Biodegradable polymers for controlled delivery of chemotherapy with and without radiation therapy in the monkey brain.
Brem H; Tamargo RJ; Olivi A; Pinn M; Weingart JD; Wharam M; Epstein JI
J Neurosurg; 1994 Feb; 80(2):283-90. PubMed ID: 8283268
[TBL] [Abstract][Full Text] [Related]
7. Biodegradable wafers releasing Temozolomide and Carmustine for the treatment of brain cancer.
Shapira-Furman T; Serra R; Gorelick N; Doglioli M; Tagliaferri V; Cecia A; Peters M; Kumar A; Rottenberg Y; Langer R; Brem H; Tyler B; Domb AJ
J Control Release; 2019 Feb; 295():93-101. PubMed ID: 30605703
[TBL] [Abstract][Full Text] [Related]
8. Brain biocompatibility of a biodegradable, controlled-release polymer in rats.
Tamargo RJ; Epstein JI; Reinhard CS; Chasin M; Brem H
J Biomed Mater Res; 1989 Feb; 23(2):253-66. PubMed ID: 2708412
[TBL] [Abstract][Full Text] [Related]
9. Paracrine immunotherapy with interleukin-2 and local chemotherapy is synergistic in the treatment of experimental brain tumors.
Sampath P; Hanes J; DiMeco F; Tyler BM; Brat D; Pardoll DM; Brem H
Cancer Res; 1999 May; 59(9):2107-14. PubMed ID: 10232596
[TBL] [Abstract][Full Text] [Related]
10. Tumor radiosensitization by sustained intratumoral release of bromodeoxyuridine.
Doiron A; Yapp DT; Olivares M; Zhu JX; Lehnert S
Cancer Res; 1999 Aug; 59(15):3677-81. PubMed ID: 10446981
[TBL] [Abstract][Full Text] [Related]
11. The role of BCNU polymer wafers (Gliadel) in the treatment of malignant glioma.
Nagpal S
Neurosurg Clin N Am; 2012 Apr; 23(2):289-95, ix. PubMed ID: 22440872
[TBL] [Abstract][Full Text] [Related]
12. Interstitial taxol delivered from a biodegradable polymer implant against experimental malignant glioma.
Walter KA; Cahan MA; Gur A; Tyler B; Hilton J; Colvin OM; Burger PC; Domb A; Brem H
Cancer Res; 1994 Apr; 54(8):2207-12. PubMed ID: 7909720
[TBL] [Abstract][Full Text] [Related]
13. Local delivery of doxorubicin for the treatment of malignant brain tumors in rats.
Lesniak MS; Upadhyay U; Goodwin R; Tyler B; Brem H
Anticancer Res; 2005; 25(6B):3825-31. PubMed ID: 16312042
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of controlled release of a cyclophosphamide derivative with polymers against rat gliomas.
Judy KD; Olivi A; Buahin KG; Domb A; Epstein JI; Colvin OM; Brem H
J Neurosurg; 1995 Mar; 82(3):481-6. PubMed ID: 7861228
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and characterization of polyanhydride for local BCNU delivery carriers.
Kim MS; Seo KS; Seong HS; Cho SH; Lee HB; Hong KD; Kim SK; Khang G
Biomed Mater Eng; 2005; 15(3):229-38. PubMed ID: 15912003
[TBL] [Abstract][Full Text] [Related]
16. Poly(sebacic acid-co-ricinoleic acid) biodegradable carrier for paclitaxel: in vitro release and in vivo toxicity.
Shikanov A; Vaisman B; Krasko MY; Nyska A; Domb AJ
J Biomed Mater Res A; 2004 Apr; 69(1):47-54. PubMed ID: 14999750
[TBL] [Abstract][Full Text] [Related]
17. Synthetic, implantable polymers for IUdR radiosensitization of experimental human malignant glioma.
Yuan X; Dillehay LE; Williams JR; Williams JA
Cancer Biother Radiopharm; 1999 Jun; 14(3):187-202. PubMed ID: 10850303
[TBL] [Abstract][Full Text] [Related]
18. Resorbable polymer microchips releasing BCNU inhibit tumor growth in the rat 9L flank model.
Kim GY; Tyler BM; Tupper MM; Karp JM; Langer RS; Brem H; Cima MJ
J Control Release; 2007 Nov; 123(2):172-8. PubMed ID: 17884232
[TBL] [Abstract][Full Text] [Related]
19. Interstitial chemotherapy of experimental brain tumors: comparison of intratumoral injection versus polymeric controlled release.
Buahin KG; Brem H
J Neurooncol; 1995 Nov; 26(2):103-10. PubMed ID: 8787852
[TBL] [Abstract][Full Text] [Related]
20. The role of minocycline in the treatment of intracranial 9L glioma.
Weingart JD; Sipos EP; Brem H
J Neurosurg; 1995 Apr; 82(4):635-40. PubMed ID: 7897527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
